Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Sun Life Financial
SLF
$46.1B
| $3.41M | ﹤0.01% |
73,581
-73,581
| -50% | -$3.26M |
|
952
MasterBrand
MBC
$1.06B
| $3.41M | ﹤0.01% |
+451,709
| New | +$3.7M |
|
953
Omega Healthcare
OHI
$15.1B
| $3.4M | ﹤0.01% |
121,749
-379,173
| -76% | -$11.4M |
|
954
Exelixis
EXEL
$13.5B
| $3.39M | ﹤0.01% |
211,443
-1,465,863
| -87% | -$23.9M |
|
955
West Pharmaceutical
WST
$24B
| $3.38M | ﹤0.01% |
14,379
+4,609
| +47% | +$1.09M |
|
956
The Ensign Group
ENSG
$10.3B
| $3.38M | ﹤0.01% |
35,744
+26,484
| +286% | +$2.4M |
|
957
W.W. Grainger
GWW
$65.5B
| $3.36M | ﹤0.01% |
6,035
+1
| +0% | +$564 |
|
958
Builders FirstSource
BLDR
$7.09B
| $3.35M | ﹤0.01% |
51,659
-57,901
| -53% | -$3.62M |
|
959
PG&E
PCG
$38.5B
| $3.35M | ﹤0.01% |
205,981
-832,987
| -80% | -$12.6M |
|
960
EPAM Systems
EPAM
$5.47B
| $3.33M | ﹤0.01% |
10,166
+2,765
| +37% | +$940K |
|
961
International Flavors & Fragrances
IFF
$20.3B
| $3.33M | ﹤0.01% |
31,759
-638,655
| -95% | -$62.8M |
|
962
MKS Inc
MKSI
$20.5B
| $3.32M | ﹤0.01% |
39,214
-29,892
| -43% | -$2.4M |
|
963
Ameren
AEE
$30.4B
| $3.31M | ﹤0.01% |
37,224
-11,142
| -23% | -$936K |
|
|
EPHY
964
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
| $3.29M | ﹤0.01% |
329,149
-329,149
| -50% | -$3.28M |
|
|
DFS
965
DELISTED
Discover Financial Services
DFS
| $3.29M | ﹤0.01% |
33,625
-36,629
| -52% | -$3.69M |
|
966
Cenovus Energy
CVE
$55.5B
| $3.29M | ﹤0.01% |
169,505
-175,505
| -51% | -$3.37M |
|
967
WillScot Mobile Mini Holdings
WSC
$4.41B
| $3.28M | ﹤0.01% |
72,591
-74,863
| -51% | -$3.36M |
|
|
ELIQ
968
DELISTED
Electriq Power Holdings, Inc.
ELIQ
| $3.27M | ﹤0.01% |
321,556
-321,552
| -50% | -$3.22M |
|
|
PPL
969
PPL Corp
PPL
$26.6B
| $3.25M | ﹤0.01% |
111,361
-587,697
| -84% | -$16.2M |
|
970
Blue Owl Capital
OWL
$6.95B
| $3.24M | ﹤0.01% |
305,320
-1,158,728
| -79% | -$12.2M |
|
971
AdaptHealth
AHCO
$1.45B
| $3.21M | ﹤0.01% |
166,799
-192,683
| -54% | -$4.07M |
|
972
Brookfield
BN
$105B
| $3.2M | ﹤0.01% |
152,516
-1,069,988
| -88% | -$24M |
|
973
Axcelis
ACLS
$4.03B
| $3.2M | ﹤0.01% |
40,275
-39,439
| -49% | -$2.78M |
|
974
M&T Bank
MTB
$35.8B
| $3.16M | ﹤0.01% |
21,800
-18,804
| -46% | -$3.09M |
|
975
FirstEnergy
FE
$28B
| $3.16M | ﹤0.01% |
75,296
-372,764
| -83% | -$14.6M |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.